NYSEARCA:CCEL • US2288951088
The current stock price of CCEL is 3.275 USD. Today CCEL is down by 0%. In the past month the price decreased by -1.95%. In the past year, price decreased by -54.34%.
ChartMill assigns a technical rating of 0 / 10 to CCEL. When comparing the yearly performance of all stocks, CCEL is a bad performer in the overall market: 91.1% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to CCEL. CCEL has a medium profitability rating, but doesn't score so well on its financial health evaluation.
On February 27, 2026 CCEL reported an EPS of -0.47 and a revenue of 7.84M. The company missed EPS expectations (-411.98% surprise) and missed revenue expectations (-0.55% surprise).
6 analysts have analysed CCEL and the average price target is 8.67 USD. This implies a price increase of 164.73% is expected in the next year compared to the current price of 3.275.
For the next year, analysts expect an EPS growth of -38.19% and a revenue growth -4.87% for CCEL
Over the last trailing twelve months CCEL reported a non-GAAP Earnings per Share(EPS) of -0.31. The EPS decreased by -616.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -0.75% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 10.87 | 99.891B | ||
| CI | THE CIGNA GROUP | 9 | 74.103B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 101.25 | 27.175B | ||
| LH | LABCORP HOLDINGS INC | 15.32 | 22.874B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.4 | 22.691B | ||
| GH | GUARDANT HEALTH INC | N/A | 11.928B | ||
| DVA | DAVITA INC | 11.34 | 10.278B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 30.12 | 8.084B | ||
| CHE | CHEMED CORP | 17 | 5.675B | ||
| RDNT | RADNET INC | 83.8 | 5.16B | ||
| OPCH | OPTION CARE HEALTH INC | 15.97 | 4.765B | ||
| HIMS | HIMS & HERS HEALTH INC | 29.08 | 3.62B | ||
| HNGE | HINGE HEALTH INC-A | 29.43 | 3.609B |
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the NYSE Arca Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. The company is headquartered in Oldsmar, Florida and currently employs 82 full-time employees. The firm operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The firm stores approximately 240,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The firm markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
CRYO-CELL INTL INC
700 Brooker Creek Blvd, Suite 1800
Oldsmar FLORIDA US
CEO: David Portnoy
Employees: 82
Phone: 18137492104
Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. The company is headquartered in Oldsmar, Florida and currently employs 82 full-time employees. The firm operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The firm stores approximately 240,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The firm markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
The current stock price of CCEL is 3.275 USD.
CRYO-CELL INTL INC (CCEL) has a dividend yield of 12.21%. The yearly dividend amount is currently 0.25.
CCEL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
The next ex-dividend date for CRYO-CELL INTL INC (CCEL) is May 21, 2025.
CRYO-CELL INTL INC (CCEL) currently has 82 employees.
You can find the ownership structure of CRYO-CELL INTL INC (CCEL) on the Ownership tab.